Green Cross Up 0.79% This Morning... Individuals Net Sell 257,126 Shares Over Past 5 Days

As of 9:30 a.m. on November 4, 2020, Green Cross is trading at 381,000 KRW, up 0.79% from the previous day. Trading volume stands at 475,211 shares, which is 16.92% of the previous day's volume. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

On November 3, Seo Geunhee, a researcher at Samsung Securities, stated, "Regarding the COVID-19 vaccine Fill & Finish contract manufacturing (CMO), the unit selling price per dose is expected to be determined after the main contract is signed. As the possibility of contract manufacturing agreements with multiple companies has been raised, and due to increased market demand for Fill & Finish, we believe an adjustment in the unit price is necessary. Therefore, we have raised the estimated unit selling price per dose from $1 to $2, resulting in an upward revision of our 2021 revenue and operating profit estimates by 10% and 21%, respectively, compared to previous forecasts." He set the target price for Green Cross at 350,000 KRW.

Over the past five days, individual investors have been net sellers of 257,126 shares of Green Cross, while foreign investors and institutions have been net buyers of 61,785 shares and 203,188 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was automatically generated in real-time by a news automation algorithm jointly developed by Asia Economy and the financial AI company Thinkpool.

This content was produced with the assistance of AI translation services.